These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36627003)

  • 1. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS
    Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D
    J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of
    Liang Y; Xie Y; Liu X; Yu L; Yan H; Shang Z; Wu Y; Cai X; Shi W; Du J; Yang Z
    Drug Des Devel Ther; 2024; 18():2169-2187. PubMed ID: 38882048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YuPingFengSan ameliorates LPS-induced acute lung injury and gut barrier dysfunction in mice.
    Wang Y; Wang Y; Ma J; Li Y; Cao L; Zhu T; Hu H; Liu H
    J Ethnopharmacol; 2023 Aug; 312():116452. PubMed ID: 37019161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YuPingFeng (YPF) upregulates caveolin-1 (CAV1) to alleviate pulmonary fibrosis through the TGF-β1/Smad2 pathway.
    Chen X; Wei M; Li GD; Sun QL; Fan JQ; Li JY; Yun CM; Liu DM; Shi H; Qu YQ
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117357. PubMed ID: 37898439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
    Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
    J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large-scale transcriptional analysis reveals herb-derived ginsenoside F2 suppressing hepatocellular carcinoma via inhibiting STAT3.
    Tan X; Ma X; Dai Y; An J; Yu X; Li S; Liao Y; Pei T; Tang Y; Gui Y; Zhou S; Guo D; Deng Y; Hu K; Wang D
    Phytomedicine; 2023 Nov; 120():155031. PubMed ID: 37666060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the mechanism of action of Saposhnikovia divaricata and its key phytochemical on rheumatoid arthritis based on network pharmacology and bioinformatics.
    Jiang Y; Zhong S; Tan H; Fu Y; Lai J; Liu L; Weng J; Chen H; He S
    J Ethnopharmacol; 2024 Mar; 322():117586. PubMed ID: 38104871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the mechanisms underlying the therapeutic effect of the
    Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
    Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on molecular mechanism of Solanum nigrum in treatment of hepatocarcinoma based on network pharmacology and molecular docking].
    Liu JH; Lyu DY; Zhou HM; Kuang WH; Chen ZX; Zhang SJ
    Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):163-168. PubMed ID: 32237426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis.
    Wei J; Ma L; Liu W; Wang Y; Shen C; Zhao X; Zhao C
    J Ethnopharmacol; 2021 Aug; 276():114174. PubMed ID: 33932512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma.
    Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
    Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobelia chinensis Lour inhibits the progression of hepatocellular carcinoma via the regulation of the PTEN/AKT signaling pathway in vivo and in vitro.
    Luo J; Chen QX; Li P; Yu H; Yu L; Lu JL; Yin HZ; Huang BJ; Zhang SJ
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116886. PubMed ID: 37429502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
    Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
    BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma.
    Li X; Zhou M; Chen W; Sun J; Zhao Y; Wang G; Wang B; Pan Y; Zhang J; Xu J
    BMC Complement Med Ther; 2024 May; 24(1):208. PubMed ID: 38816744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of
    Khalid HR; Aamir M; Tabassum S; Alghamdi YS; Alzamami A; Ashfaq UA
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yu Ping Feng San, an ancient Chinese herbal decoction containing Astragali Radix, Atractylodis Macrocephalae Rhizoma and Saposhnikoviae Radix, regulates the release of cytokines in murine macrophages.
    Du CY; Choi RC; Zheng KY; Dong TT; Lau DT; Tsim KW
    PLoS One; 2013; 8(11):e78622. PubMed ID: 24244327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
    Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
    Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
    Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
    Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of peanut skin components for treating hepatocellular carcinoma via network pharmacology and in vitro experiments.
    Li S; Liu W; Wang TT; Chen TQ; Guo JC
    Chem Biol Drug Des; 2024 Jan; 103(1):e14428. PubMed ID: 38230768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.